Monitoring minimal residual disease and controlling drug resistance in chronic myeloid leukaemia patients in treatment with imatinib as a guide to clinical management / Martinelli, G., Iacobucci, I., Soverini, S., Cilloni, D., Saglio, G., Pane, F., Baccarani, M.. - In: HEMATOLOGICAL ONCOLOGY. - ISSN 0278-0232. - 24:4(2006), pp. 196-204. [10.1002/hon.792]
Monitoring minimal residual disease and controlling drug resistance in chronic myeloid leukaemia patients in treatment with imatinib as a guide to clinical management
PANE, FABRIZIO;
2006
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
